Haick Jennifer M, Brueggemann Lioubov I, Cribbs Leanne L, Denning Mitchell F, Schwartz Jeffrey, Byron Kenneth L
Department of Molecular Pharmacology and Therapeutics, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois.
Department of Cell & Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois.
Am J Physiol Lung Cell Mol Physiol. 2017 Jun 1;312(6):L822-L834. doi: 10.1152/ajplung.00567.2016. Epub 2017 Mar 10.
Kv7 potassium channels have recently been found to be expressed and functionally important for relaxation of airway smooth muscle. Previous research suggests that native Kv7 currents are inhibited following treatment of freshly isolated airway smooth muscle cells with bronchoconstrictor agonists, and in intact airways inhibition of Kv7 channels is sufficient to induce bronchiolar constriction. However, the mechanism by which Kv7 currents are inhibited by bronchoconstrictor agonists has yet to be elucidated. In the present study, native Kv7 currents in cultured human trachealis smooth muscle cells (HTSMCs) were observed to be inhibited upon treatment with histamine; inhibition of Kv7 currents was associated with membrane depolarization and an increase in cytosolic Ca ([Ca]). The latter response was inhibited by verapamil, a blocker of L-type voltage-sensitive Ca channels (VSCCs). Protein kinase C (PKC) has been implicated as a mediator of bronchoconstrictor actions, although the targets of PKC are not clearly established. We found that histamine treatment significantly and dose-dependently suppressed currents through overexpressed wild-type human Kv7.5 (hKv7.5) channels in cultured HTSMCs, and this effect was inhibited by the PKC inhibitor Ro-31-8220 (3 µM). The PKC-dependent suppression of hKv7.5 currents corresponded with a PKC-dependent increase in hKv7.5 channel phosphorylation. Knocking down or inhibiting PKCα, or mutating hKv7.5 serine 441 to alanine, abolished the inhibitory effects of histamine on hKv7.5 currents. These findings provide the first evidence linking PKC activation to suppression of Kv7 currents, membrane depolarization, and Ca influx via L-type VSCCs as a mechanism for histamine-induced bronchoconstriction.
最近发现Kv7钾通道在气道平滑肌舒张中表达且具有重要功能。先前的研究表明,用支气管收缩激动剂处理新鲜分离的气道平滑肌细胞后,天然Kv7电流受到抑制,并且在完整气道中,抑制Kv7通道足以诱导细支气管收缩。然而,支气管收缩激动剂抑制Kv7电流的机制尚未阐明。在本研究中,观察到用组胺处理后,培养的人气管平滑肌细胞(HTSMC)中的天然Kv7电流受到抑制;Kv7电流的抑制与膜去极化和胞质Ca([Ca])增加有关。后一种反应被L型电压敏感性钙通道(VSCC)阻滞剂维拉帕米抑制。蛋白激酶C(PKC)被认为是支气管收缩作用的介质,尽管PKC的靶点尚未明确确定。我们发现组胺处理显著且剂量依赖性地抑制培养的HTSMC中过表达的野生型人Kv7.5(hKv7.5)通道的电流,并且这种效应被PKC抑制剂Ro-31-8220(3μM)抑制。PKC依赖性抑制hKv7.5电流与PKC依赖性增加hKv7.5通道磷酸化相对应。敲低或抑制PKCα或将hKv7.5丝氨酸441突变为丙氨酸,消除了组胺对hKv7.5电流的抑制作用。这些发现提供了首个证据表明PKC激活与抑制Kv7电流、膜去极化以及通过L型VSCC的Ca内流相关,这是组胺诱导支气管收缩的一种机制。